You will receive an e-mail with instructions to reset your password

Hereditary cancers

Screening for risks of the following cancers: breast, ovarian, prostate, pancreatic, stomach, colorectal and skin.

This study interprets your genes to determine the risk you have to suffer from different types of cancer of hereditary character. It provides you with key information so that you can take preventive and/or follow-up measures to reduce your risk of developing the disease or detect it early.
One in six deaths worldwide

is due to cancer, according to 2017 data.(1)

Early detection of breast cancer

ensures 90% survival.(2)

It is estimated that between 5-10% of cancer cases have a hereditary component,

reaching 20% in certain types of cancer.(3)

About 25% of hereditary breast and ovarian cancer cases

are due to mutations in the BRCA1 and BRCA2 genes.(4)

Hereditary cancers
  • Study the following hereditary cancer syndromes:
    • Lynch Syndrome
    • Gorlin Syndrome
    • Birt-Hogg-Dube Syndrome
    • Hereditary breast and ovarian cancer syndrome
    • Cowden Syndrome
    • Li-Fraumeni syndrome
    • Nijmegen Syndrome
    • Peutz-Jeghers syndrome
    • Pancreatic cancer/melanoma syndrome
    • Juvenile Polyposis Syndrome
    • Hereditary Prostate Cancer
    • Hereditary diffuse gastric cancer
    • Gliome
    • Melanome
    • Type 1 Neurofibromathose
    • Familial adenomatous polyposis
    • Polyposis associated with MUTYH
    • Associated adenomatous polyposis POLD1 and POLE
    • Hereditary mixed polyposis syndrome
    • BAP1-associated tumor predisposition syndrome
  • Identifies variants in 40 genes related to cancer and hereditary cancer syndromes.
  • A genetic counsellor approved by medmesafe will accompany you before and after the analysis by video consultation.
icono de tiempo 8 weeks
icono de mundo Spain
icono de la muestra Saliva
icono de genes Whole Exome Secuencing
icono de tiempo
  • Counting from the reception of the sample in the laboratory.
icono de mundo
  • Only available in Spain at the moment
icono de la muestra
  • Collection of saliva.
icono de genes
  • Whole exome sequencing (WES) with illumina platform (HiSeq X10, NovaSeq 6000).
  • Average coverage 110x sequencing >97% at ≥20x.
  • Compliant with the Laboratory Developed Test (LDT) regulations and performed in a CLIA-certified laboratory (CLIA#22D2089381)
  • CAP Accreditation (College of American Pathologists).
  • All the reports are reviewed by an expert medical team with more than 10 years of experience in Whole Genome and Exome sequencing, including members of the Personal Genome Project of Harvard Medical School.
  • Possible outcomes:
    • Pathogenic variants, probably pathogenic variants and variants of uncertain significance (VOUS) are reported.
  • Technical limitations:
    • Inversions and complex structural rearrangements such as translocations are not detected.
    • For regions of high homology, del/dup analysis is not performed.
    • Copy number variants in APC, ATM, CHEK2, GREM1, MSH6, PALB2, PMS2, PTEN, STK11, and TP53 are detected at multi-exon resolution (2 or more exons).
    • EPCAM variant detection is limited to del/dup analysis of the 3’ end of the gene.
  • The genes included are associated with several cancer types, however there may be other genes associated with hereditary cancer that are not covered by this panel.
  • No secondary findings are reported outside the established panel.



Rod Paley


Graeme McKenzie


Daniel Crigan


The analysis detects 40 genes related to different types of cancer".
Multi-gene analysis is more effective than single gene/type cancer testing, as it detects a greater number of people at risk".
The report of the test results will help the doctor decide the best course of action for each case".

  • To find out if your genes determine that you are at risk for these cancers.
  • If you have one, it is recommended to know if it will be transmitted to your descendants and to personalize the treatments.

  • If you have a family history of cancer diagnosed before age 50.
  • If there are diagnoses of cancer in different family members and in different generations.
  • If you have several types of tumors.
  • If you have cancer, in order to know its possible hereditary character.
  • If a pattern of cancer typical of certain hereditary predispositions is present in your family (ex: colorectal and endometrial cancer in the Lynch Syndrome).

Go Up

More information


How does it work?

  1. elige tu test genético
    Select desired analysis and a specialist, then you have a video-consultation.
  2. frotis bucal para análisis
    Receive a sample collector kit at home that will be picked up by a courier.
  3. instrucciones de uso
    One of our partner labs makes the analysis.
  4. instrucciones de uso
    Your healthcare professional presents your results via videoconference.
Go further

You can help by sharing this information with your contacts or doctor

Other tests related to this:

This site uses both its own cookies and third-party cookies in order to obtain statistical data on the browsing activity of its users. You accept these cookies by continuing to browse the Portal or by clicking ACCEPT You can find information on how to enable/disable browser cookies reading our Cookie Policy (Manage settings)

This site uses both its own cookies and third-party cookies (files which are installed on the user’s device and which record browsing information) in order to obtain statistical data on the browsing activity of its users. By clicking ACCEPT or by continuing to browse the Portal, you accept that PROMETUM SPAIN S.L.U. may store and use these cookies. To find out more, please read our Cookie Policy where you can also find information on how to enable/disable browser cookies. ACCEPT (Manage settings)

You can set your preferences and choose how you want your data to be used for the following purposes.
medmesafe - required cookies
Information regarding your user preferences in order to offer you better navigation.
Always active
Google analytics - Navigation information
We collect information on how users use our platform to analyze navigation and to be able to improve the user experience.
Save preferences